BTIG Downgrades Sionna Therapeutics (SION) to Neutral, 'we were wrong on our PreciSION CF call'

August 10, 2026 3:14 PM

BTIG analyst Kambiz Yazdi downgraded Sionna Therapeutics (NASDAQ: SION) from Buy to Neutral.The analyst comments "We will be straightforward: we ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found